Boundless Bio Inc BOLD

$2.58 -0.04 (-1.34%)

Valuation

Market cap
60,510,000
Revenue TTM
$0
Net income TTM
$-58,200,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
27,331
Avg volume
182,050
Day's range
$2.56 – $2.62
Shares out
22,748,000
Stochastic %K
14%
Beta
-0.03
Analysts
Hold
Price target
$4.00

Price

Company profile

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as...

Show more

Boundless Bio, Inc., a clinical-stage oncology company, develops interrogating extrachromosomal DNA (ecDNA) directed therapies for treating patients with oncogene amplified cancers. Its lead product candidate is BBI-940, an ecDNA-directed therapeutic candidate (ecDTx) that is in Phase 1/2 clinical trial in patients with estrogen receptor positive and human epidermal growth factor receptor 2 negative breast cancer, as well as patients with triple-negative breast cancer luminal androgen receptor subtype. The company was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. Boundless Bio, Inc. was incorporated in 2018 and is headquartered in San Diego, California.

Industry
Biotechnology
Sector
Healthcare
Phone
858 766 9912
Website
https://boundlessbio.com
Address
10955 Alexandria Way, Suite 100, San Diego, United States

Latest news

Stocktwits

focafoca99 Aug 28, 10:26 PM
$BOLD amends its merger agreement, adding RSU conversion mechanics and pre-funded warrant terms.
0 replies
JuggernautRaider Aug 11, 3:52 PM
$BOLD a long shot
0 replies
Gairbear Aug 5, 2:07 PM
$BOLD watching
0 replies
Gtrading1234 Jul 24, 5:25 PM
$BOLD
0 replies
JuggernautRaider Jul 21, 10:12 AM
$BOLD monitoring 🤔
0 replies
Shawshank_book_keeper Jul 16, 6:45 AM
$BOLD add this to the win list!
0 replies
OnlyFibs Jul 14, 4:29 PM
INSIDER BUY WATCH — biggest buys this week $GGAL — $2.16M across 3 buys by insider Moret Silvestre Vila (Jul 7-8) $PRQR — $499.5K across 2 buys by CEO Daniel de Boer, doubling his stake twice in a week (Jul 7 & 9) $BOLD — $364K across 6 separate buys by insider Kevin Tang, buying almost daily (Jul 6-13) $YEXT — $398K single buy by insider Daniel Englander, +117% stake increase (Jul 13)
0 replies
AZOZ Jul 14, 1:43 PM
$CYAB $BOLD Insider trading!
0 replies